Salud financiera de hoja de balance de Advanced Enzyme Technologies
Salud financiera controles de criterios 6/6
Advanced Enzyme Technologies tiene un patrimonio de accionistas total de ₹13.0B y una deuda total de ₹388.6M, lo que sitúa su ratio deuda-patrimonio en 3%. Sus activos y pasivos totales son ₹14.4B y ₹1.5B respectivamente. El BAIT de Advanced Enzyme Technologies es de ₹1.6B, por lo que su ratio de cobertura de intereses es de 103.8. Tiene efectivo e inversiones a corto plazo que ascienden a ₹4.7B.
Información clave
3.0%
Ratio deuda-patrimonio
₹388.61m
Deuda
| Ratio de cobertura de intereses | 103.8x |
| Efectivo | ₹4.68b |
| Patrimonio | ₹12.99b |
| Total pasivo | ₹1.45b |
| Activos totales | ₹14.44b |
Actualizaciones recientes sobre salud financiera
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07Are Insiders Buying Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stock?
Jul 29How Does Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Fare As A Dividend Stock?
Jul 17Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Jul 04Do Advanced Enzyme Technologies's (NSE:ADVENZYMES) Earnings Warrant Your Attention?
Jun 28Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹7.4B) de ADVENZYMES superan a sus pasivos a corto plazo (₹874.0M).
Pasivo a largo plazo: Los activos a corto plazo de ADVENZYMES (₹7.4B) superan a sus pasivos a largo plazo (₹577.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ADVENZYMES tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ADVENZYMES ha pasado de 7.2% a 3% en los últimos 5 años.
Cobertura de la deuda: La deuda de ADVENZYMES está bien cubierta por el flujo de caja operativo (341.5%).
Cobertura de intereses: Los pagos de intereses de la deuda de ADVENZYMES están bien cubiertos por el BAIT (103.8x cobertura).